Smeijer JD, Gomez MF, Rossing P, Heerspink HJL, et al. The effect of the endothelin receptor antagonist atrasentan on insulin resistance in phenotypic clusters of patients with type 2 diabetes and chronic kidney disease. Diabetes Obes Metab 2024 Nov 6. doi: 10.1111/dom.16041.
PMID: 39503150